Device Companies
Study: 1 in 10 Recalled St. Jude Medical Riata Lead Coatings Fail Within Six Years
February 25, 2013 2:43 pm | by Mass Device | News | CommentsDanish researchers reported this week that their latest studies of St. Jude Medical's recalled Riata defibrillator leads found that 1 in 10 had poked through their coating in an average of just over 5 years. The study included 298 Danish patients, representing "virtually every living patient in Denmark who received Riata defibrillator leads," according to Heartwire.
Jury Awards $3.35 Million to Victim of Prolift Vaginal Mesh Injuries
February 25, 2013 2:38 pm | by Bio-Medicine.Org | News | CommentsA New Jersey state court jury today awarded $3.35 million to 47-year-old Linda Gross , a woman whose life took a significant turn for the worse in 2006 after she received a Prolift vaginal mesh implant manufactured by Johnson & Johnson's Ethicon unit. Concluding the trial of the first of the 2,100 personal injury cases...
Medtronic Adds to Intersect ENT's $30M Series D Round
February 25, 2013 12:52 pm | by Mass Device | News | CommentsMedtronic is once again backing sinus implant developer Intersect ENT, this time in a $30 million Series D round led by new investor Norwest Venture Partners. All of Intersect's existing "significant" backers participated in the latest round, including Kleiner Perkins Caufield & Byers, U.S. Venture Partners, PTV Sciences and Medtronic, according to a press release.
Which Medical Device Companies Are the Best to Work for?
February 25, 2013 12:38 pm | by Mass Device | News | CommentsJohnson & Johnson (NYSE:JNJ) tops the charts as the best medical device company to work for according to Glassdoor.com, a database of anonymously posted information about salaries, interviews and jobs from current and former medical device industry employees.
Regulators Probe J&J's Marketing of Recalled Hip Implants
February 25, 2013 12:04 pm | by Mass Device | News | CommentsFederal investigators recently launched an additional inquiry into Johnson & Johnson and its DePuy Orthopaedics subsidiary, taking a closer look at marketing practices surrounding a line of recalled metal-on-metal hips. J&J confirmed in regulatory filings last week that the U.S. State Attorney's Office for the District of Massachusetts and the Civil Division of the U.S. Justice Dept...
Bard to Present at Raymond James Institutional Investor Conference
February 25, 2013 10:30 am | by The Associated Press | News | CommentsMURRAY HILL, N.J.--(BUSINESS WIRE)--Feb 25, 2013--C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Raymond James Institutional Investor Conference in Orlando, Florida on March 4, 2013. Christopher S. Holland, senior vice president and chief financial officer, will discuss...
Iowa Resident Brings Suit Against Stryker For Damages Caused By Recalled Hip Implant
February 21, 2013 5:01 pm | by The Associated Press | News | CommentsNEW YORK--(BUSINESS WIRE)--Feb 21, 2013--Wendy Fleishman and Lexi J. Hazam of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that Karla Krogman of West Des Moines, Iowa, filed a lawsuit against Stryker Orthopaedics charging that the company manufactured...
OrbusNeich Rides Patent Win Over Boston Scientific to Germany, Netherlands
February 21, 2013 12:24 pm | by Mass Device | News | CommentsOrbusNeich is taking a recent patent infringement win against Boston Scientific even further, filing lawsuits in both Germany and the Netherlands to allege patent infringement over stent technology. OrbusNeich claims Boston Scientific's Promus Element, Promus Element Plus, Taxus, and other stents are infringing on a pair of patents.
Covidien Closes Enrollment in Iliac Stent Studies
February 21, 2013 11:38 am | by Mass Device | News | CommentsCovidien said it closed enrollment in a pair of its Visibility and Durability iliac stent clinical studies. The prospective, multinational studies are designed to compare balloon stents with self-expanding stents in the iliac arteries for treating peripheral artery disease.
Medical Equipment Suppliers in Good Health - Research Report on Bruker Corporation, Agilent Technologies Inc., General Electric Company, Becton, Dickinson and Co. and Thermo Fisher Scientific Inc.
February 21, 2013 8:01 am | by The Associated Press | News | CommentsToday, National Traders Association announced new research reports highlighting Bruker Corporation (NASDAQ: BRKR), Agilent Technologies Inc. (NYSE: A), General Electric Company (NYSE: GE), Becton, Dickinson and Co. (NYSE: BDX) and Thermo Fisher Scientific Inc. (NYSE: TMO). Today's readers...
Stryker Recommends More Vigilant Monitoring of Patients with Recalled Hip Implants
February 20, 2013 3:09 pm | by Mass Device | News | CommentsStryker's Australian arm provided national health regulators with updated recommendations for monitoring patients who received the company's now-recalled ABG II Modular hip systems. Australia's Therapeutic Goods Admin. issued the new guidelines for patient follow-up, advising regular blood testing and soft tissue cross-sectional imaging for all ABG II patients, even in the absence of pain or swelling.
Premier healthcare alliance awards new radiation treatment system contract to member hospital
February 20, 2013 2:55 pm | by Mass Device | News | CommentsGroup purchasing organization Premier inked a contract with Philips Healthcare for radiation treatment planning. The new team-based radiation treatment program was available to the Philips Healthcare network on Jan. 1, but Premier made the announcement this month.
Medtronic Cuts Estimated Medical Device Tax Impact in Half
February 19, 2013 5:07 pm | by Mass Device | News | CommentsMedtronic joins fellow medical device giants in forecasting lower 2013 medtech tax costs than previously anticipated. Medical device maker Medtronic (NYSE:MDT) this week became the latest in a string of medtech giants who have pared back their expectations of the impact of the 2.3% medical device sales tax.
Medtronic's Q3 Sales, Earnings Rise
February 19, 2013 8:17 am | by Mass Device | News | CommentsMedtronic posted profit and sales gains during its fiscal 3rd quarter this morning, eating Wall Street analysts' earnings expectations along the way. The Fridley, Minn.-based company, which is the world's largest pure-play medical device company, said profits were up 5.7% on sales growth of 2.8% for the 3 months ended Jan. 25.
Terumo Medical Corporation Files Patent Infringement Lawsuit Against Vascular Solutions And Lepu Medical Technology Company
February 19, 2013 7:31 am | by The Associated Press | News | CommentsTerumo Medical Corporation (Terumo), today announced that it has filed a patent infringement lawsuit against Vascular Solutions Inc. and Lepu Medical Technology (Beijing) Co., Ltd in the U.S. District Court of New Jersey. The complaint alleges that R BandT Radial Hemostasis Device ...
Turnabout is Fair Play for Boston Scientific in Guidant Lawsuit
February 18, 2013 11:44 am | by Mass Device | News | CommentsFor Boston Scientific and its ongoing legal woes over the blockbuster acquisition of Guidant Corp. , you win some and you lose some. The Natick, Mass.-based medical device company won a bid in December to compel the release of Medicare documents in a whistleblower lawsuit accusing Guidant and its corporate parent of concealing problems with Guidant's implantable cardiac defibrillators.
Emergency Nurses Association Announces Corporate Sponsors for Leadership Conference
February 18, 2013 9:28 am | by Bio-Medicine.Org | News | CommentsDES PLAINES, Ill. , Feb. 18, 2013 /PRNewswire-USNewswire/ -- The Emergency Nurses Association (ENA) today announced the corporate sponsors for the ENA Leadership Conference to be held in Fort Lauderdale on February 28- March 3, 2013. This year's Strategic Sponsors are Hill-Rom, Stryker and Vidacare; the Strategic Supporters are Blue Jay Consulting and FreemanWhite ED Design Team; and th...
Abbott's MitraClip Gets a Date with the FDA
February 15, 2013 2:28 pm | by Mass Device | News | CommentsThe FDA's Circulatory System Devices Panel will review data and make recommendations on Abbott's MitraClip aortic valve repair system. Abbott (NYSE:ABT) landed an FDA panel date to review its MitraClip aortic valve repair system, according to an FDA notice.
Stryker to Present at Investor Conferences
February 15, 2013 1:48 pm | by The Associated Press | News | CommentsKalamazoo, Michigan - February 15, 2013 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conferences: February 25, 2013 - 10:20 a.m. Eastern Time Citi 2013 Global Healthcare Conference New York, New York March 5, 2013 - 10:40 a.m. Eastern Time...
St. Jude Looks Beyond Blood Pressure for Benefits of Renal Denervation
February 15, 2013 12:06 pm | by Mass Device | News | CommentsSt. Jude Medical is aiming to take its renal denervation therapy a step further, looking for signs that the minimally invasive treatment improves health beyond lowering high blood pressure in patients with uncontrolled hypertension. The company's new Enlightnment trial is looking for long-term effects of renal denervation therapy...
Bard to Present at Citi 2013 Global Healthcare Conference
February 14, 2013 4:21 pm | by The Associated Press | News | CommentsMURRAY HILL, N.J.--(BUSINESS WIRE)--Feb 14, 2013--C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Citi 2013 Global Healthcare Conference in New York City on February 27, 2013. Timothy M. Ring, chairman and chief executive officer, will discuss the Company in a presentation...
More Hip Recalls for Johnson & Johnson
February 14, 2013 3:36 pm | by Mass Device | News | CommentsA German newspaper reports that healthcare giant Johnson & Johnson is recalling another of its metal-on-metal hip implants. International reports today suggest that healthcare giant Johnson & Johnson (NYSE:JNJ) recalled its Adept hip replacement system, another in its line of troubled metal-on-metal hip implants.
A "New Era" for Boston Scientific?
February 14, 2013 11:18 am | by Mass Device | News | CommentsBoston Scientific (NYSE:BSX) expects positive sales growth for the company by the 2nd half of 2013, CFO Jeffrey Capello told MassDevice.com in an interview. A return to positive sales growth would end nearly 2.5 years of sliding revenues, and the medical device maker still has some rough patches to navigate, he said.
Boston Scientific Amid Headquarters Shift
February 14, 2013 7:29 am | by Mass Device | News | CommentsMassachusetts medical device titan Boston Scientific (NYSE:BSX) will need to add 50 new employees for each 500 square-feet of new space at its new Marlborough headquarters, in compliance with the 2nd phase of a long-term tax incentive program agreed upon by the city. The company announced in November 2012 that it would move 13 miles of its previous headquarters in Natick, Mass.
Medical Device Tax Will Cost Boston Scientific $75M this Year, CEO Says
February 12, 2013 2:33 pm | by Mass Device | News | CommentsBoston Scientific CEO Michael Mahoney tells investors that the new 2.3% medical device sales tax will cost the company about $75 million in 2013. Medtech giant Boston Scientific (NYSE:BSX) estimates that its 2013 medical device tax obligation will amount to around $75 million, president & CEO Michael Mahoney told an audience the company's analyst meeting in New York today.
